Retatrutide reaches its maximum dose faster (12 weeks vs 16-20 weeks) and produces greater weight loss despite a lower milligram dose than tirzepatide
These SkinMedica products are not intended to be drug products that diagnose, treat, cure, or prevent any disease or condition
The Wegovy Summary of Product Characteristics indicates no clinically relevant interactions are expected with typical cold remedy ingredients
In descending order, the medications used included serotonin-norepinephrine reuptake inhibitors (used by 182 patients), gabapentin (155 patients), tricyclic antidepressants (134 patients), trazodone (59 patients), pregabalin (46 patients), muscle relaxants (45 patients), montelukast (26 patients), -blockers (21 patients), aripiprazole (12 patients), histamine 1 or histamine 2 blockers (11 patients), naltrexone (8 patients), amphetamine- or methylphenidate-based stimulants (8 patients), midodrine (7 patients), fludrocortisone (6 patients), non-amphetamine stimulants (4 patients), pyridostigmine (4 patients), -blockers (1 patient), and droxidopa (1 patient)
Frontiers in endocrinology, 5, 140
